{"id":275904,"date":"2025-06-18T16:00:11","date_gmt":"2025-06-18T21:00:11","guid":{"rendered":"https:\/\/dallasinnovates.com\/?p=275904"},"modified":"2025-06-18T16:06:37","modified_gmt":"2025-06-18T21:06:37","slug":"caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation","status":"publish","type":"post","link":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/","title":{"rendered":"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation"},"content":{"rendered":"

A North Texas biotech with AI at its core is now a public company. Caris Life Sciences, founded in 2008 and headquartered in Irving, made its Nasdaq debut Wednesday under the ticker CAI, raising $494 million in its initial public offering.<\/strong><\/p>\n

Shares priced at $21 and opened at $27<\/a>, according to Reuters, with the debut performance bringing the market capitalization to around $7.66 billion.<\/p>\n

The listing has also minted a new billionaire. Founder and CEO David Halbert now worth an estimated $3.3 billion<\/a>, Forbes reports.<\/p>\n

Caris, launched by Halbert after his mother’s battle with cancer<\/a>, applies artificial intelligence to tissue- and blood-based molecular profiling for cancer diagnosis and therapy selection.<\/p>\n

The Irving, Texas headquartered company has processed more than 6.5 million tests, raised over $1.86 billion since 2018, and recently opened a $45 million liquid biopsy lab in Phoenix to expand its Caris Assure platform.<\/p>\n

As Dallas Innovates reported earlier this month, the IPO was led by BofA Securities, J.P. Morgan, Goldman Sachs, and Citigroup.<\/p>\n

\n

Don’t miss what’s next. Subscribe\u00a0to\u00a0Dallas\u00a0Innovates.<\/h2>\n

Track Dallas-Fort Worth’s business and innovation landscape with our curated news in your inbox Tuesday-Thursday.<\/p>\n

\n
\n
One quick signup, and you’re done.<\/p>\n
<\/div>\n<\/div>\n<\/form>\n<\/div>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.<\/p>\n","protected":false},"author":465,"featured_media":172300,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[8,15],"tags":[189237,37099,175071,203302,3217,7405,90579,204879,9958],"class_list":["post-275904","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-enterprise","category-startup","tag-bofa-securities","tag-caris-life-sciences","tag-citigroup","tag-david-halbert","tag-forbes","tag-goldman-sachs","tag-j-p-morgan","tag-marketwatch","tag-nasdaq"],"acf":[],"yoast_head":"\nCaris Life Sciences Debuts on Nasdaq With $7.66B Valuation » Dallas Innovates<\/title>\n<meta name=\"description\" content=\"Irving-based Caris Life Sciences raised $494 million in its Nasdaq IPO, giving the AI-driven cancer diagnostics firm a $7.66 billion valuation. Founder David Halbert is now a newly minted biotech billionaire, Forbes reports.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation\" \/>\n<meta property=\"og:description\" content=\"Irving-based Caris Life Sciences raised $494 million in its Nasdaq IPO, giving the AI-driven cancer diagnostics firm a $7.66 billion valuation. Founder David Halbert is now a newly minted biotech billionaire, Forbes reports.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/\" \/>\n<meta property=\"og:site_name\" content=\"Dallas Innovates\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/dallasinnovates\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-18T21:00:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-18T21:06:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"970\" \/>\n\t<meta property=\"og:image:height\" content=\"464\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Quincy Preston and David Seeley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@dallasinnovates\" \/>\n<meta name=\"twitter:site\" content=\"@dallasinnovates\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Quincy Preston and David Seeley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/\"},\"author\":{\"name\":\"Quincy Preston and David Seeley\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/person\/e34dfa394c4ccc0994452332e64ce8b1\"},\"headline\":\"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation\",\"datePublished\":\"2025-06-18T21:00:11+00:00\",\"dateModified\":\"2025-06-18T21:06:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/\"},\"wordCount\":200,\"publisher\":{\"@id\":\"https:\/\/dallasinnovates.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg\",\"keywords\":[\"BofA Securities\",\"Caris Life Sciences\",\"Citigroup\",\"David Halbert\",\"Forbes\",\"Goldman Sachs\",\"J.P. Morgan\",\"MarketWatch\",\"Nasdaq\"],\"articleSection\":[\"Business\",\"Startup\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\/\/dallasinnovates.com\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/\",\"url\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/\",\"name\":\"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation » Dallas Innovates\",\"isPartOf\":{\"@id\":\"https:\/\/dallasinnovates.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg\",\"datePublished\":\"2025-06-18T21:00:11+00:00\",\"dateModified\":\"2025-06-18T21:06:37+00:00\",\"description\":\"Irving-based Caris Life Sciences raised $494 million in its Nasdaq IPO, giving the AI-driven cancer diagnostics firm a $7.66 billion valuation. Founder David Halbert is now a newly minted biotech billionaire, Forbes reports.\",\"breadcrumb\":{\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage\",\"url\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg\",\"contentUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg\",\"width\":970,\"height\":464,\"caption\":\"David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/dallasinnovates.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dallasinnovates.com\/#website\",\"url\":\"https:\/\/dallasinnovates.com\/\",\"name\":\"Dallas Innovates\",\"description\":\"What's new + next in Dallas - Fort Worth\",\"publisher\":{\"@id\":\"https:\/\/dallasinnovates.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dallasinnovates.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/dallasinnovates.com\/#organization\",\"name\":\"Dallas Innovates | Published by Dallas Next\",\"url\":\"https:\/\/dallasinnovates.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg\",\"contentUrl\":\"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg\",\"width\":1782,\"height\":410,\"caption\":\"Dallas Innovates | Published by Dallas Next\"},\"image\":{\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/dallasinnovates\/\",\"https:\/\/x.com\/dallasinnovates\",\"https:\/\/www.instagram.com\/dallasinnovates\/\",\"https:\/\/www.linkedin.com\/company\/dallas-innovates\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/person\/e34dfa394c4ccc0994452332e64ce8b1\",\"name\":\"Quincy Preston and David Seeley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/dallasinnovates.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/a785799d308e8e7a1acca4442af6eb79895e57cb4fcb2d7b7880b9b6646c95f1?s=96&d=retro&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/a785799d308e8e7a1acca4442af6eb79895e57cb4fcb2d7b7880b9b6646c95f1?s=96&d=retro&r=g\",\"caption\":\"Quincy Preston and David Seeley\"},\"url\":\"https:\/\/dallasinnovates.com\/author\/quincy-david\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation » Dallas Innovates","description":"Irving-based Caris Life Sciences raised $494 million in its Nasdaq IPO, giving the AI-driven cancer diagnostics firm a $7.66 billion valuation. Founder David Halbert is now a newly minted biotech billionaire, Forbes reports.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/","og_locale":"en_US","og_type":"article","og_title":"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation","og_description":"Irving-based Caris Life Sciences raised $494 million in its Nasdaq IPO, giving the AI-driven cancer diagnostics firm a $7.66 billion valuation. Founder David Halbert is now a newly minted biotech billionaire, Forbes reports.","og_url":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/","og_site_name":"Dallas Innovates","article_publisher":"https:\/\/www.facebook.com\/dallasinnovates\/","article_published_time":"2025-06-18T21:00:11+00:00","article_modified_time":"2025-06-18T21:06:37+00:00","og_image":[{"width":970,"height":464,"url":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg","type":"image\/jpeg"}],"author":"Quincy Preston and David Seeley","twitter_card":"summary_large_image","twitter_creator":"@dallasinnovates","twitter_site":"@dallasinnovates","twitter_misc":{"Written by":"Quincy Preston and David Seeley","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#article","isPartOf":{"@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/"},"author":{"name":"Quincy Preston and David Seeley","@id":"https:\/\/dallasinnovates.com\/#\/schema\/person\/e34dfa394c4ccc0994452332e64ce8b1"},"headline":"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation","datePublished":"2025-06-18T21:00:11+00:00","dateModified":"2025-06-18T21:06:37+00:00","mainEntityOfPage":{"@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/"},"wordCount":200,"publisher":{"@id":"https:\/\/dallasinnovates.com\/#organization"},"image":{"@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage"},"thumbnailUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg","keywords":["BofA Securities","Caris Life Sciences","Citigroup","David Halbert","Forbes","Goldman Sachs","J.P. Morgan","MarketWatch","Nasdaq"],"articleSection":["Business","Startup"],"inLanguage":"en-US","copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/dallasinnovates.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/","url":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/","name":"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation » Dallas Innovates","isPartOf":{"@id":"https:\/\/dallasinnovates.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage"},"image":{"@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage"},"thumbnailUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg","datePublished":"2025-06-18T21:00:11+00:00","dateModified":"2025-06-18T21:06:37+00:00","description":"Irving-based Caris Life Sciences raised $494 million in its Nasdaq IPO, giving the AI-driven cancer diagnostics firm a $7.66 billion valuation. Founder David Halbert is now a newly minted biotech billionaire, Forbes reports.","breadcrumb":{"@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#primaryimage","url":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg","contentUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2021\/05\/CarisLifeSciences_970-courtesy.jpg","width":970,"height":464,"caption":"David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]"},{"@type":"BreadcrumbList","@id":"https:\/\/dallasinnovates.com\/caris-life-sciences-debuts-on-nasdaq-with-7-66b-valuation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dallasinnovates.com\/"},{"@type":"ListItem","position":2,"name":"Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation"}]},{"@type":"WebSite","@id":"https:\/\/dallasinnovates.com\/#website","url":"https:\/\/dallasinnovates.com\/","name":"Dallas Innovates","description":"What's new + next in Dallas - Fort Worth","publisher":{"@id":"https:\/\/dallasinnovates.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dallasinnovates.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/dallasinnovates.com\/#organization","name":"Dallas Innovates | Published by Dallas Next","url":"https:\/\/dallasinnovates.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/","url":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg","contentUrl":"https:\/\/dallasinnovates.com\/wp-content\/uploads\/2018\/09\/Dallas-Innovates-logo-purple.jpg","width":1782,"height":410,"caption":"Dallas Innovates | Published by Dallas Next"},"image":{"@id":"https:\/\/dallasinnovates.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/dallasinnovates\/","https:\/\/x.com\/dallasinnovates","https:\/\/www.instagram.com\/dallasinnovates\/","https:\/\/www.linkedin.com\/company\/dallas-innovates"]},{"@type":"Person","@id":"https:\/\/dallasinnovates.com\/#\/schema\/person\/e34dfa394c4ccc0994452332e64ce8b1","name":"Quincy Preston and David Seeley","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/dallasinnovates.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/a785799d308e8e7a1acca4442af6eb79895e57cb4fcb2d7b7880b9b6646c95f1?s=96&d=retro&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a785799d308e8e7a1acca4442af6eb79895e57cb4fcb2d7b7880b9b6646c95f1?s=96&d=retro&r=g","caption":"Quincy Preston and David Seeley"},"url":"https:\/\/dallasinnovates.com\/author\/quincy-david\/"}]}},"_links":{"self":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/posts\/275904","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/users\/465"}],"replies":[{"embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/comments?post=275904"}],"version-history":[{"count":0,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/posts\/275904\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/media\/172300"}],"wp:attachment":[{"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/media?parent=275904"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/categories?post=275904"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dallasinnovates.com\/wp-json\/wp\/v2\/tags?post=275904"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}